Ligand · ENT
ENT · 3(R)-methylcarbamoyl-7-sulfoamino-3,4-dihydro-1H-isoquinoline-2-carboxylic acid tert-butyl ester
ENT, 3(R)-methylcarbamoyl-7-sulfoamino-3,4-dihydro-1H-isoquinoline-2-carboxylic acid tert-butyl ester (C16 H23 N3 O6 S, 385.4 g/mol), in the MolNFT structures on GenesisL1: bound in 2 records (1 PDB entry). Every binding site with its…
- Component
- ENT
- Formula
- C16 H23 N3 O6 S
- Class
- ligand
- Structures
- 2
- PDB entries
- 1
Binding sites
ENT in 2 structures; the first of them:
- 2F6Y · Protein tyrosine phosphatase 1B with sulfamic acid inhibitors · ENT A608 · binds TYR46, VAL49, LYS120, ASP181, PHE182, CYS215, SER216, ALA217 and 5 more
- 2F6Y · Protein tyrosine phosphatase 1B with sulfamic acid inhibitors · ENT A608 · binds TYR46, VAL49, LYS120, ASP181, PHE182, CYS215, SER216, ALA217 and 5 more
Residues it binds most
GLY 2, ALA 2, ARG 2, ASP 2, CYS 2, GLN 2, ILE 2, LYS 2, PHE 2, SER 2 (residue and the binding sites it lines).
Found with
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.